# Alloantibodies in Pediatric Heart Transplantation

> **NCT01005316** · — · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 290 (actual)

## Conditions studied

- Pediatric Heart Transplantation
- Pediatric Heart Transplant Recipients

## Interventions

- **DRUG:** Induction Therapy
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate Mofetil
- **PROCEDURE:** Intraoperative plasma exchange/pheresis
- **PROCEDURE:** Short-term post-operative plasmapheresis
- **DRUG:** Immunoglobulins, Intravenous
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT01005316
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 290 (ACTUAL)
- **Why stopped:** Inability to meet accrual goals within the funding period.
- **Last updated:** 2017-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005316, "Alloantibodies in Pediatric Heart Transplantation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01005316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*